13th Annual Clinical Trials Summit 2022
Share
Now
WHY SHOULD YOU ATTEND?
Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.
Event Speakers
MUKESH KUMAR
Cipla
SADHNA J
Sun Pharma
SADHNA J
Sun Pharma
SADHNA JOGLEKAR, Head, Global Drug Development India, Novartis
Decisive, results-oriented, transformational and passionate medical affairs professional. Proven track record of successfully leading Country, Area and Regional medical affairs teams across APAC, China, Japan, LATAM, Russia/CIS, Middle East, and Turkey, with a focus on value creation for stakeholders as the innovative pipeline moves from clinical development into commercialization phase across broad spectrum of therapeutic areas including Oncology, GI, Respiratory, Cardio-metabolic, Dermatology, Anti-infectives etc. Special interest in people development to build cutting edge medical affairs teams that act as the scientific face of specialty care pharma companies to the external stakeholders.
PRATIK SHAH
Bharat Serums and Vaccines
PRATIK SHAH
Bharat Serums and Vaccines
PRATIK SHAH, Vice President Medical Affairs, Bharat Serums and Vaccines
RAGHURAM J
Tenthpin
RAGHURAM J
Tenthpin
RAGHURAM JANAPAREDDY, Partner & Managing Director – India, Tenthpin
Raghuram Janapareddy has over 35 years of experience in Lifesciences, Healthcare and Manufacturing industry, working in the Pharma, Aeronautics, Steel, Automotive, Retail, CPG, Oil & Gas, & Information Technology space.
At Tenthpin, he leads the global Center of Excellence of Innovation for life sciences from India responsible for the country operations as well as co-innovation programs with Customers and SAP.
Prior to joining Tenthpin, he was working as a Director atNASSCOM Center of Excellence of IoT/AI in India, where he was leading the Lifesciences and Healthcare Vertical. At NASSCOM he created one of the largest healthcare eco-system in India under the brand name LHIF (Lifesciences & Healthcare Innovation Forum) to drive digital adoption by the industry. Besides other responsibilities, his main focus was accelerating the Digital Health Innovation and Adoption, working on public healthcare programs with societal impact, nurturing thought leadership & policy advocacy and engaging the industry in strategic partnerships.
He is one of the few healthcare leaders in the world to be enrolled onto the Roster of Experts in WHO Digital Health Technical Advisory Group (DHTAG). Recently he has been recognized by Medgate Today International magazine as one of The Top Strategists of Healthcare to follow in 2021.
Earlier, Raghu worked for nearly 17 years at SAP in India and Germany locations. At SAP he led multiple SAP Implementations in India including the first SAP SCM implementation. He was the Program Manager in setting up Supply Chain CoE at Walldorf, US and Singapore. His cross-domainexperienceincludes:Innovation & Digital Transformation, Project/Program Management, Operations Management, Global Delivery Management, Offshore Service Delivery Management, Strategic/Tactical Vendor Management, Competency/Practice/CoE Management, Supply Chain Management, Solution/Product Management, Process Management, etc.
Raghuram is a frequent contributor of articles and blogs on social media. He organized multiple thought leadership summits and events, participating as a panel moderator, speaker and master of ceremonies.
DIVAKAR KOLLI
Cipla
DIVAKAR KOLLI
Cipla
DIVAKAR KOLLI, Director and Head - Clinical & Non-Clinical QA, Cipla
- Working as Director – Clinical and Non-clinical QA at Cipla; working with Cipla for ~7 years; Instrumental in set-up of clinical &non-clinical QA function at Cipla.
- Total 17+years of QA experience which includes both CRO and pharma experience
- Handled 25+ regulatory inspections in both BA/BE and clinical trials set-up
- Conducted/managed 200+ site/CRO audits in more than 10 countries
TUSHAR SAKPAL
Novartis
KIRAN MARTHAK
Veeda Clinical Research
KIRAN MARTHAK
Veeda Clinical Research
KIRAN MARTHAK, Non - Executive Director, Veeda Clinical Research
Dr. Kiran Marthak is Director- Medical and Regulatory Affairs in Veeda Clinical Research Limited. Dr. Marthak comes with a rich experience in Clinical Research of nearly 40 years. Dr. Marthak has conducted many Phase 1 studies including First in Human studies, and complex clinical trials. He has held senior positions in several Indian and Global pharmaceutical companies such as Ciba – Geigy (Novartis), GSK, Pfizer and Ranbaxy, and in leading CROs and has experience in conducting clinical trials across several geographies including USA, UK, Europe, China, Japan and South Africa. Dr. Marthak’s last assignment was as a Member of the Board of Directors in Lambda Therapeutic Research Ltd. Dr. Marthak was a Board member during our formative years.
Dr. Marthak is highly respected amongst regulatory authorities for his knowledge of international clinical research guidelines. He is one of the accredited members for GCP training by CDSA, India and contributed to the New Clinical Trial Rules implemented in March 2019. Dr. Marthak is also the Co-Chairman of the Medical Committee of IDMA and a member of the Pharmaceutical and Biotech Committees of the Confederation of Indian Industries. He is a renowned speaker in International and National Conferences, besides being actively involved in academics. Dr. Marthak is a qualified M.D. in Internal Medicine from Grant Medical College, Fellow of American College of Clinical Pharmacology, Fellow of Royal Society of Medicine, U.K. and Fellow of Faculty of Pharmacology, University of London.
MILIND ANTANI
Nishith Desai Associates
MILIND ANTANI
Nishith Desai Associates
MILIND ANTANI, Leader, Pharma and Healthcare, Nishith Desai Associates
Dr. Milind Antani is a Partner in charge of the Pharma & Healthcare Practice a at the multi-skilled, research-based international law firm, Nishith Desai Associates with offices in Mumbai- Nariman Point, Silicon Valley, Bangalore, Singapore, New Delhi and Mumbai – BKC, Munich and New York. He is also partner in-charge of Social Sector practice and Nanotechnology practice.
Dr. Antani represents clients on strategy matters including corporate mergers and acquisitions, investments, regulatory and transactional matters, intellectual property prosecution and litigation, collaborations including joint ventures and formation of new companies. He also advises clients in e-Health and tele-medicine on business strategy from legal and regulatory perspective.
DEEPA ARORA
CLINEXEL Life Sciences
DEEPA ARORA
CLINEXEL Life Sciences
DEEPA ARORA, Chief Executive Officer, CLINEXEL Life Sciences
Deepa is an Experienced Clinical Development and Drug Safety physician. She served in leadership positions in pharma companies for almost two decades, leading global clinical research and pharmacovigilance activities. Currently she is the Chief Executive Officer of Clinexel Life Sciences Pvt Ltd.
CLINEXEL is an agile, customer focused full service, Clinical Research Organization, that provides clinical research, pharmacovigilance, regulatory, auditing and medical writing services to pharma, biotech and medical device companies. At CLINEXEL, our mission is to partner with early-stage pharma and biotech companies for fast and efficient clinical development of their innovations.
RAHUL GUPTA
USV
RAHUL GUPTA
USV
RAHUL GUPTA, Sr. Vice President – Regulatory Affairs, USV
• Rahul Gupta is presently Senior Vice President – Regulatory Affairs at USV Pvt Ltd. Prior to USV, he has worked in Sun Pharma, Piramal enterprise and many other pharmaceutical companies.
• Rahul has over 25 years of experience in the various pharmaceutical area. He has regulatory experience for development of new molecules from discovery to Phase I to Phase III.
• He has worked on cancer, anti-analgesic, anti-infective, metabolic disorder drugs in area of new drug development- having experience of successfully filing about 60 Phase I / II and III IND / CT applications across various continent, which includes USA, Europe, Australia, Canada and India.
• He has also worked on more than 70 ANDA’s and generic European submission for various dosage form- solid orals, parenterals, nasal sprays and complex generics etc, also having experience of DMFs/CEPs/ASMFs in regulated countries.
• He is M.Sc in Pharmaceutical chemistry and MBA in Operational management. He was also an adjunct faculty at Mumbai University (Bombay college of pharmacy), NMIMS and many other academic institutes in India.
RAKESH PATEL
Veeda Clinical Research
RAKESH PATEL
Veeda Clinical Research
RAKESH PATEL, Associate Vice President – Clinical Operations (Head – Projects), Veeda Clinical Research
Dr. Rakesh is an experienced professional with over 17 years of experience in managing clinical operations, which includes Phase I to Phase IV clinical trials, real world studies, and glucose clamp studies.
He has joined us from Zydus Healthcare Limited, where his most recent position was Sr. General Manager-Medical Affairs, Clinical R & D. Prior to Zydus, Dr. Rakesh was associated with Eris Lifesciences Ltd, Lambda, Wockhardt and Jubilant Lifesciences in Clinical Operations, where he handled the Clinical trials business.
Dr. Rakesh is MD in Pharmacology and comes with rich experience and deep knowledge of Clinical Trials functions. We are excited to have him as part of our team at Veeda.
ANIKET JOSHI
Novartis
ANIKET JOSHI
Novartis
ANIKET JOSHI, Associate Global Portfolio Delivery Director, Novartis
Total experience of 14+ years in Clinical Research Industry, worked across different roles ranging from Site monitoring, Project management, Line management, Regional operations & currently in Global Clinical Operations. Presently working as an Associate Global Portfolio Delivery Director in Novartis, responsible for overall trial monitoring operations delivery for the assigned portfolio at global level
DILIP PAWAR
Unichem Laboratories
DILIP PAWAR
Unichem Laboratories
DILIP PAWAR, Head - Medical Affairs and Pharmacovigilance, Unichem Laboratories
Heading Medical Affairs, PV and Global Clinical Development
I am oncologist and also Covid Expert
MUKESH GORI
Novartis
CHIRAG TRIVEDI
Sanofi
CHIRAG TRIVEDI
Sanofi
CHIRAG TRIVEDI, Clinical Study Unit Cluster Head, Sanofi
Work Experience:
Am currently working in Sanofi as Sr. Director and Head of Clinical Study Unit India and South East Asia Cluster - overseeing clinical studies in India, Singapore, Malaysia, Thailand, Indonesia, Philippines, Bangladesh, Sri Lanka and Vietnam.
Have been with Sanofi since 2006 and have handled various roles and responsibilities in these years.
Prior to Sanofi, have worked in a CRO and prior to that, in a Central Lab.
From April 2017 to March 2021, was the President of Indian Society for Clinical Research (ISCR) for a total of two terms. As a Society, ISCR brings together all those who are engaged in clinical research activities in India and provides a forum for exchange of information and learning. ISCR aims to build awareness of clinical research as a specialty in India and to facilitate its growth in the country while helping to evolve the highest standards of quality and ethics.
Experienced in the fields of Clinical Research, Clinical Quality Assurance, Medical Excellence, Pharmacovigilance, Bioavailability & Bioequivalence Studies, and Business Development.
Educational Qualification:
Ph.D. in Pharmacology
Additional information:
- Havebeennominatedas anexternalexaminerbytheUniversity of MumbaiforthePh.D.(Tech.)andfor MastersinPharmaceutical SciencesExamination(speciality–Pharmacology)for evaluatingresearch thesis.
- Havebeena Speakeratvarious national and International conferences
KEDAR NAYAK
GSK
KEDAR NAYAK
GSK
KEDAR NAYAK, Head - Clinical Development, GSK
• Kedar joined GSK India in 1996 as a medical representative and subsequently transitioned to Clinical Operations in 2005, during his career he has been holding a variety of clinical research roles across Phase II/III in increasing capacity from being CRA, Study Manager, Clinical Research Manager, Head of Clinical Operations at Vietnam, India and Area Director for Russia, Middle East Africa.
• In his current role as GM/Head - Clinical Development, he is accountable for E2E study delivery of local interventional studies (Phase 4, BA/BE studies), partnering with Medical affairs towards development and execution of evidence generation strategies within India, Brazil and Emerging markets.
• Kedar has completed his MSc from Seth GS Medical College and MBA (HR) from NMIMS.
• Member of ISCR Executive committee
KRISHNA C V
Dr. Reddy's Laboratories
KRISHNA C V
Dr. Reddy's Laboratories
KRISHNA C VELIGANDLA, Lead, Medical Affairs, Dr. Reddy's Laboratories
SADANAND K
Fresenius Kabi
SADANAND K
Fresenius Kabi
SADANAND KULKARNI, Head - Medical, Regulatory, Vigilance, Quality, Fresenius Kabi
Current Position
- Head, Medical, Regulatory, Vigilance, Quality, Fresenius Kabi India Pvt. Ltd., since Jan 2019
Professional experience:
- Vice President, Medical Affairs and Clinical Research, Fresenius Kabi India Pvt. Ltd., Pune/Gurgaon: July 2011 to 2018 (with Fresenius Kabi, since 2003)
- Assistant Medical Director, Serum Institute of India, Pune., Sept 2000-May 2003
- Teaching profession: February 1996 - August 2000
- M.D. (Clinical Microbiology): 1995: BJ Medical College, Pune
- DIB (Diploma in International Business) 2003: Symbiosis Institute of International Business
- Trained in clinical nutrition and volume therapy, Fresenius Kabi Advanced Nutrition course and Fresenius Kabi Advanced course in transfusion alternatives
Clinical/research interests:
- Co author of papers presented in ESPEN 2004, 2005, PENSA 2003, NATA, 2006 in the field of Clinical Nutrition and Volume Therapy
- 4 publications in the field of Clinical Microbiology and Vaccinology
Special areas of interest:
- Clinical Nutrition and immunonutrition
- Hospital acquired infections
- Clinical trials under GCP
GOPAL NANDAN
Oncquest Laboratories
GOPAL NANDAN
Oncquest Laboratories
GOPAL NANDAN, Sr. Manager: Clinical Trials, Oncquest Laboratories
Gopal Nandan with more than 15 years of experience in clinical research industry working upon project management and business development specially 11 years into core clinical central lab looking upon clinical trial projects with B.Tech in Bio-informatics as educational background with intent and interest towards clinical research with moto of life Forward Ever. He had been handling all indications and phases of trials with perspective from central lab including many vaccines studies working with almost all pharma and CRO’s giant and still miles to go and currently associated with Oncquest Laboratories Ltd. where aiming to take his organization to a next level in the industry
INDRANIL P
Ipca Laboratories
INDRANIL P
Ipca Laboratories
INDRANIL PURKAIT, Sr. General Manager and Head Medical Affairs, Ipca Laboratories
VISHWAS SOVANI
Pharmawisdom
ROSHAN PAWAR
Alkem Laboratories
SAKHARAM G
Renovare Healthcare
“A critical guide for successfully conducting clinical trials”
Event Schedule
Meet and to network with your conference colleagues.
08:30 – Coffee and registration – An opportunity to meet and to network with your conference colleagues.
09:20 – Chairperson opening remarks
PRATIK SHAH, Vice President Medical Affairs, Bharat Serums and Vaccines
CHALLENGES & OPPORTUNITIES
09:30 – Getting Future Ready – Standards Driven Automations – Possibility & Opportunities
- CRF concepts and submission concepts
- Third part data and data cleaning
- How standards (global + company) can drive automations?
- SDTM/ADaM concepts and TFL concepts
TUSHAR SAKPAL, Director - Clinical Data Standards & Automation, Novartis
10:00 – DISCUSSION WITH EXPERTS: Key changes and visible trends in clinical trials
- Challenges and lessons learned from Covid-19 trials
- What can we anticipate for clinical development post pandemic? Barriers in adoption of new normal
- Opportunities and challenges of collecting wearable data in decentralized trials
- The growth of hybrid trial & virtual trials in India.
- Prioritizing study risks and learning from past experiences
- Digital transformation and AI in clinical trials
- Planning for better clinical trials globally.
- Clinical trials in Nutraceuticals: The new frontier?
Moderator:
DILIP PAWAR, Head - Medical Affairs and Pharmacovigilance, Unichem Laboratories
Panellist:
SANDESH SAWANT, Senior Director, Medical Services Head - Clinical Trials, Cipla
RAKESH PATEL, Associate Vice President – Clinical Operations (Head – Projects), Veeda Clinical Research
ANIKET JOSHI, Associate Global Portfolio Delivery Director, Novartis
CHIRAG TRIVEDI, Clinical Study Unit Cluster Head, Sanofi
KEDAR NAYAK, Head - Clinical Development, GSK
KRISHNA C VELIGANDLA, Lead, Medical Affairs, Dr. Reddy's Laboratories
ARUN BHATT, Consultant – Clinical Research & Development
11:00 – Morning Coffee/Tea & Discussion
PATIENT SAFETY
11:20 – DISCUSSION WITH EXPERTS: Ensuring the patient safety and centricity in clinical trials.
- What are key challenges in patient safety? Ways to overcome and better alternatives.
- Enhancing patient-site centricity and clinical innovation through technology
- What can we do better to improve patient recruitment?
- Impact of technology in field of clinical trials - where are we heading with these developments and what’s next?
- Role of DCT methods in the process of patient enrolment and safety.
- How much data is used and what information is shared with the patient?
- Risk-based monitoring (RBM) – Is ensuring patient safety?
Moderator:
RAGHURAM JANAPAREDDY, Partner & Managing Director – India, Tenthpin
Panellist:
MUKESH KUMAR, Senior Vice President & Head, Clinical R&D, Cipla
KIRAN MARTHAK, Non - Executive Director, Veeda Clinical Research
MUKESH GORI, Associate Director - ESP Management PV Operations, Novartis
MANGALA KOTNIS, Head Regional Medical Affairs, Abbott
INDRANIL PURKAIT, Sr. General Manager and Head Medical Affairs, Ipca Laboratories
ROSHAN PAWAR, Associate General Manager, Alkem Laboratories
12:20 – Oncology Clinical Development - Efficient Early Phase Execution
- Focus on robust science and geographies levers to optimize cost, timelines and robust decisions
DEEPA ARORA, Founder - Director, CLINEXEL Life Sciences
12:40 –Networking luncheon
CRO RESPONABILITIES
13:50 – DISCUSSION WITH EXPERTS: Risk identification and quality management in sponsorship
- What are the key market trends and challenges driving opportunities and outsourcing?
- Recognizing the challenges of navigating multiple stakeholders.
- Focusing on the relationship between CROs and sponsors – What are the distractions?
- Discussing the current industrial trends globally and in India as well.
- End-to-end strategic partnership and managing the communications gap
- Ensuring that high quality data is collected as part of CRO collaboration
- How can sponsors successfully manage the EU CTR change?
Moderator:
VISHWAS SOVANI, Founder Director, Pharmawisdom
Panellist:
PRATIK SHAH, Vice President Medical Affairs, Bharat Serums and Vaccines
DIVAKAR KOLLI, Associate Director and Head - Clinical & Non-Clinical QA, Cipla
VAIBHAV SALVI, Head – Medical Information, Asia, Sanofi
ASHWANI PANDITA, General Manager Quality Management & Training, Global Clinical Research Operations, Glenmark
SAKHARAM GARALE, Founder & CEO, Renovare Healthcare Solutions
14:40 – Central Lab: Oncquest Laboratories Ltd: Capability Presentation & Role of Central Lab in Clinical Trials
GOPAL NANDAN, Sr. Manager: Clinical Trials, Oncquest Laboratories
15:00 – Afternoon Tea/Coffee
15:20 – Early phase development: Is India ready?
SADHNA JOGLEKAR, Head, Global Drug Development India, Novartis
REGULATORY
15:50 – DISCUSSION WITH EXPERTS: Recent changes in regulatory aspect of clinical trials in India
- Ensuring and maintaining compliance with the rules and regulations.
- Following the pandemic, what are the regulatory challenges for the CRO industry?
- Delays in approval from regulatory agencies. What needs to be done?
- Protecting safety: Standardizing and streamlining the regulatory process
Moderator:
MILIND ANTANI, Leader, Pharma and Healthcare, Nishith Desai Associates
Panellist:
YASMIN SHENOY, Director-Regulatory Affairs, Sanofi
RAHUL GUPTA, Sr. Vice President – Regulatory Affairs, USV
HARSHAD KOTHAWADE, Head-Regulatory Management & Trade Compliance, Merck
SADANAND KULKARNI, Head-Medical, Regulatory, Vigilance, Quality, Fresenius Kabi
16:40 - Chairperson’s closing remarks and end of conference
PRATIK SHAH, Vice President Medical Affairs, Bharat Serums and Vaccines
Share
Now
Event Sponsors & Partners
Veeda Clinical Research
Company Description:
Veeda Clinical Research Limited (“Veeda”) together with its subsidiary, Bioneeds India Private Limited (“Bioneeds”), and its joint venture, Ingenuity Biosciences Private Limited (“Ingenuity”), (together referred to as the “Veeda Group”) offers a comprehensive portfolio of clinical, preclinical and bio/analytical services to support innovator, biosimilar and generic drug development programs of our global clientele.
We are an independent, institutional investors owned, Board governed and professionally managed contract research group offering scientific leadership, global quality management systems and long term operational and financial stability through a continuing investment in our people, processes, systems, infrastructure, technology and a deep commitment to quality.
Together, we serve clients globally in the following industries:
- Pharmaceutical and Biopharmaceutical
- Agrochemical and Industrial Chemicals
- Herbal/Nutraceuticals
- Medical Devices
Tenthpin
Introduction of Tenthpin Management Consultants
Tenthpin Management Consultants is headquartered in Basel (Switzerland) with global presence in Germany, USA, India, Singapore, Hongkong, China, UK and Portugal. Tenthpin is a boutique consultancy organization with deep expertise in Life Sciences industry segments such as, Pharma & Biotech, Medical technology, Healthcare and Animal Health.
We strive to be our client’s trusted advisor and business & technology consultants, who understand the unique challenges within each sector across the entire value chain. We provide independent, unbiased advice and services to our clients by combining our industry and process knowledge with the latest technology drivers (in particular, SAP Technologies) making the difference in any transformational change. Our ambition is to be the leading business and technology consultancy that understands the unique challenges within the different industry segments in Life Sciences.
We work globally with our clients in Europe, Asia, and the Americas to provide solutions to complex industry challenges from small to large. We are currently working on co-innovations with SAP on major pharma topics like Batch Release Hub, Intelligent Clinical Supplies Management. Cell and Gene Therapy, Cold Chain Monitoring. Intelligent Clinical Supplies Management Solution is launched recently, and the Batch Release Hub Solution will be launched by end of June 2022.
We provide services in Project and Program Management, Organizational Change Management, Quality Assessment and Assurance, Mergers, Acquisitions & Divestitures, Process and Value Chain consulting, Robotics Process Automation, Analytics. Our solutions are based on future-proof technology and tailored to the specific challenges of the life sciences industry.
Working with almost all the major Lifesciences Companies across the globe (Top 17 pharma companies out of 20), Tenthpin focuses on data-driven digital transformation initiatives. We are dedicated in making a transformational impact for our clients. Our clients’ success is built on collaborating in joint teams that follow high standards and principles to achieve sustainable benefits and impact. We steer the boat through stormy waters, navigating our clients into the future. Our engagement model starts with preliminary workshop followed by short assessment study, designing long-term transformation roadmap and engage in implementing the roadmap.
In March 2021, Tenthpin opened its Centre of Excellence for Innovation at Bangalore-India with highly experienced satellite teams working from different locations like Pune, Hyderabad, Chennai etc. The Team from India is focusing on digital transformation initiatives at our global clients and also on the futuristic co-innovation programs along with SAP.
In 2020, the CIO-Review selected Tenthpin as one of the top 10 companies that are at the forefront of providing pharma and life sciences solutions and transforming businesses.
CLINEXEL Life Sciences
CLINEXEL is a full service CRO. We provide science driven customized, cost- effectiveand time sensitive efficient early phase clinical development solutions. We are providing end to end clinical trial, regulatory, pharmacovigilance and medical writing services to pharma, biotech and medical device companies.
CLINEXEL Senior Management have strong experience in large pharma and biotech companies therefore, understand the business needs and challenges of clinical development, and key aspects of life cycle management of pharmaceuticals.
Weare supporting small and mid-size pharma and conducting Phase 1, 2 and 3 Clinical Trials for NCEs and Biologicalsand Pharmacovigilance regulatory compliance activities.
Oncquest Laboratories
Over the 20 years, Oncquest Laboratories Ltd. has been synonymous with trust and confidence in the field of diagnostic services. Oncquest have a comprehensive test menu covering basic routine tests, specialized & super specialized tests, to highly advanced Genomic testing. Oncquest started as a research entity of Dabur Research Foundation way back in 2001 and has been a forerunner in the molecular diagnostics services across India and neighbouring countries.
A favourite amongst clinicians, specialty hospitals, and other path labs, Oncquest is known for second opinion and final diagnosis, using most advanced technology and skills.
Oncquest national footprint spans over 50 Laboratories, 400+ Collection Centres & 2500+ Service Associates. It conducts over 4,000 different tests - from the routine to the most complex, spanning over 200 technologies.
Oncquest has a highly skilled and globally reputed team of qualified doctors with combined experience of 600+ years. Its logistic capabilities and Pan Asia geographical spread makes Oncquest an ideal associate for all clinical activities.
Oncquest is promoted by the Burman family - the promoters of Dabur.
Visit Our Website: www.oncquest.com
CHITKARA University
Chitkara University has been established and managed by passionate academicians with the sole mission of making each and every student “industry ready”. With more than 25,000 students and 1,700 staff from over 100 different countries, the university is proud of the impact that its graduates, life-changing research, and innovative campuses and industry developments have made – both in India and around the world.
Chitkara University has been awarded the rating of A+ by the prestigious National Assessment and Accreditation Council (NAAC), which places it among the 5% of higher education institutions (HEIs) in India to be granted such a coveted grade.
Chitkara University has consistently ranked high in the coveted NIRF Rankings under various categories including Engineering, Pharmacy, Management, Overall and Research etc.
The university maintain close links with leading blue-chip companies and professional associations to deliver their academic programs, ensure that the courses are relevant and practical to deliver the skills in demand, allowing the graduates to hit the ground running.
Both the Punjab and Himachal Pradesh campuses have been rated as one of the best in the country. The universities programs rank among the nation’s elite: Management, Computer Science Engineering, Pharmacy, User Experience and Optometry to name a few.
Visit our website: www.chitkara.edu.in
Clinevo Technologies
Clinevo Technologies is an IT firm that provides regulatory compliance and user-friendly cloud-based Software Solutions for Clinical Trials and Drug Safety / Pharmacovigilance to over 100+ Pharma/CROs.
Clinevo solutions, through their Integrated Clinical Trial Platforms, can help Clinical Trial companies conduct Decentralized Clinical Trials and Virtual Clinical Trials in a highly efficient manner.
Clinevo Cloud-based software and databases have been validated by several international authorities, including the USFDA, EMA, MHRA, Health Canada, DCGI, and others, and meet regulatory requirements such as HIPAA, ICH, GxP, 21 CFR Part 11, Annex 11, GDPR, and others.
Clinevo Technologies has a reputation for delivering solutions faster than majority of providers in this domain. Furthermore, they offer cost benefits that are unrivalled!
Some of their cloud-based Software Solutions are listed below:
Clinical Trial Systems
• Clinical Trial Management System (CTMS)
• Electronic Trial Master File (eTMF)
• Electronic Data Capture (EDC)
• eConsent
• ePRO/eCOA
• Randomization / IWRS
Drug Safety Systems
• Pharmacovigilance Database with AS2 Gateway
• Signal Detection
• Case Intake with MICC and Web Intake
Quality Management Systems
• Document Management System (DMS)
• QMS – CAPA, Change Control, Deviations and Audit Management
• Training Management / eLearn
Visit our website: www.clinevotech.com
Innvocept
Innvocept Global Solutions is a fast-growing technology-led Clinical Research & healthcare consulting company, founded by Experienced Clinical Research Industry Professionals. Innvocept has its India headquarters in Mumbai and Global footprints in Canada, Malaysia & US.
Innvocept is among the leaders to facilitate and manage Real World Evidence Based Studies and moving towards Patient Centric & De-Centralised studies. Innvocept is among the few CROs having their own Digital platforms like EDC, CTMS, IWRS, ePRO, eTMF, Remote SDV and QMS which are 21 CFR part 11 , GDPR compliant and third-party validated.
We are catering the needs of the Pharma, Biotech, Vaccines, Global CRO’s, Medical Device, Nutraceuticals, Phytomedicines, Cosmetic Research, governmental organizations, foundations, universities, and research institutions with global capabilities and extensive investigator networks.
Our services include End to End Solutions like Clinical Trial Management, Data Management service with In-House clinical technologies, Medical Writing and Publication, Quality Management, PV services, Statistics Services , Market Research and Analytics, Training, Development and Quality Solutions. Our team bring their own quality experience in conducting Pharma , Medical Devices , Registration , PMS , Investigator Initiated , Nutraceuticals & Cosmetics Studies ( Phase 1 to Phase 4) with unique skill set of domain, math and technology to help our clients move up their business value chain.
Ingram Micro
Ingram Micro helps businesses fully realize the promise of technology™—helping them maximize the value of the technology that they make, sell or use. With its vast global infrastructure and focus on cloud, mobility, technology lifecycle, supply chain and technology solutions, Ingram Micro enables business partners to operate more efficiently and successfully in the markets they serve.
No other company delivers as broad and deep a spectrum of technology and supply chain services to businesses around the world.
Ingram Micro amplifies the value of its position at the intersection of thousands of vendor, reseller and retailer partners by customizing and delivering highly targeted applications for industry verticals, business to business customers and commercial needs. From provisioning solutions for system integrators working at the heart of the network to offerings through the full lifecycle of mobile devices, SMB to global enterprise software and computing, point of sale to cloud services, professional AV to physical security—Ingram Micro is trusted by customers to have the expertise and resources to help them define and push the boundaries of what’s possible.
The company supports global operations by way of an extensive sales and distribution network throughout North America, Europe, Middle East and Africa, Latin America and Asia Pacific:
- Local sales offices and/or representatives in 59 countries
- 189 logistics centers and service centers worldwide
- Representing over 1,600 suppliers, including Acer, Apple, Cisco, Citrix, HP, IBM, Lenovo, Microsoft, Samsung, Symantec, VMware and others
- Serving more than 170,000 customers in approximately 160 countries
- Creating growth opportunities within the hard to reach SMB market as more businesses use technology to add scale, enhance services and improve productivity
- Providing support from 35,000+ associates worldwide
ADVITY
ADVITY RESEARCH PRIVATE LIMITED is an independent clinical research organization offering comprehensive clinical research solutions to pharmaceutical, biotechnology, & medical device companies. Our clinical research capabilities are combined with integrated drug safety and regulatory consulting services which will add more value to our customer portfolio. We understand the challenges of clinical programs in small & mid-size biopharma companies; with our expertise we offer tailor made clinical research solutions to our clients which are flexible and economical.
ADVITY’s Vision is to deliver strategic solutions to improve public health. ADVITY’s Belief is “ADDING VALUE WITH INTEGRITY”.
Our Comprehensive clinical research solutions include:
A) Clinical Trials
• Site Selection, Identification & site management
• Clinical Trial Monitoring
• Clinical Project Management
B) BA/BE Trials
• Healthy & Patient BE studies
C) Pharmacovigilance
• End-to-end solutions: Literature search, Case Processing, Medical information call centre, Aggregate reporting and submission to agencies
D) PK Bioanalysis
• Small & Large molecule analysis (LC-MS/MS and ELISA)
E) Glucose Clamping Studies
• Insulin BE studies
F) Statistical & Data Management
• PK & Stat analysis
• Statistical inputs
• Clinical trial data management
TIMER
Target Institute of Medical Education & Research Pvt. Ltd. (TIMER) is a CRO dedicated to provide quality clinical research services and product development specially in the field of natural sciences. Over the last 12 years, TIMER has conducted over 120 clinical trials (registered with CTRI) for companies across the spectrum like Dabur India Ltd, Lupin, Marico, Emami, Welex Laboratories to name a few. TIMER has also been the preferred CRO from AYUSH Ministry, Govt. of India for clinical studies on COVID-19. TIMER team comprises experts and experienced team members from the field of Medicine, Ayurveda, Pharmacology, Clinical Research, Pre-clinical Research and Statistics. With its office located in the prime cities of Mumbai and Pune, clinical study sites include more than 25 hospitals and research institutes spread across 21 cities in India with an investigators base of over 60 in various fields of expertise.
Product development (PD) activity at TIMER involves development of innovative and effective products complying with the regulatory requirements and meeting the highest quality and efficacy standards. The PD activity includes selection of right ingredients, testing methods, formulation development and rationality building. The products developed can be undertaken for further clinical studies. PD activities are also done in collaboration with highly esteemed research institutes and GMP certified manufacturing facilities.
Minitab – Qsutra
Qsutra® is the authorized Solutions Partner & Certified Training Provider for Minitab LLC. in India, Bangladesh, Sri Lanka, Nepal & Bhutan.
Minitab is the leading provider of Software and Services for Quality Improvement and Statistics Education. For nearly 50 years, Organizations in more than 100 countries have transformed their businesses using Minitab Products and Services.
Companies rely on Minitab to help them continually improve their Products and Services to Achieve World-Class Quality.
We support customers in successfully adopting Automation, Analytics & AI Technologies and concepts to achieve Quality & Excellence.
We serve organizations across all Manufacturing & Services Industries in India, Sri Lanka, Bangladesh, Nepal, South-East Asia, Eastern Europe & countries in the Middle East.
Our Focus: Understanding Customer needs & delivering the best-in-class solutions.
Our Core Philosophy: Systems we build must Adapt to Customer's Environment & Serve their Intended Purpose & Beyond.
Pharma Industry Uses Minitab Products and Services to; Achieve Process Optimization, Quality Risk Management, and Product Robustness
- Validate Process: Passing the 3 FDA Stage Goals
- Validate Measurement System
- Accelerate New Product development with DoE, Advanced Predictive Analytics, and Machine Learning Techniques
- Manage Risk with Monte Carlo Simulation and FMEA
- Prepare APQR easily and confidently
- Reducing Batch-to-Batch Variability
- Perform Stability Study
- Identify Outlier, Oot's&Oos's
- Manage QbD Projects Smartly
Build a strong foundation for effective use of statistical methods in a Pharmaceutical Process with Minitab Training and Consulting.
Ontime Globe
We at Ontime Globe meet the demands and pharma industry expectations for time and temperature-sensitive materials, requiring speed and care. For temperature-sensitive products like vaccines, investigational drugs, diagnostic kits, biological samples, the storage temperature is critical and this needs to be maintained during transportation.
Ontime Globe strives to maintain the integrity of the shipment throughout the transportation process. With its temperature-controlled solutions, the experts manage and proactively monitor the shipments from the time of collection to final delivery, ensuring the temperature is always maintained. We always find a way to connect patients with new medicines, in all corners of the world.
ProRelix Research
ProRelix Research is the best clinical research organization (CRO) with global service capability supporting Phase 1, 2, 3 and 4 clinical trials for Pharma, Biotech, Biopharma, Medical device, Nutraceutical and Herbal companies. Our excellent team of researchers have been working on clinical development plans of our clients with outstanding clinical research services in US, India, Australia and Europe.
We help in: Clinical Trial, Clinical Data Management, Medical Writing, Regulatory and Pharmacovigilance .
The successful growth of our organization has been achieved mainly by putting high quality and client focus at the heart of everything we do. To know more please visit
ZUELLIG PHARMA
Zuellig Pharma is one of the largest healthcare services groups in Asia and our purpose is to MAKE HEALTHACRE MORE ACCESSIBLE.
We provide world-class distribution, digital and commercial services to support the growing healthcare needs in this region.
The company started hundred years ago and has grown to become a US$13 billion business covering 18 markets with 12,000 employees.
We serve over 350,000 medical facilities and work with more than 500 clients, including the top 20 pharmaceutical companies in the world.
Zuellig Pharma Clinical Reach has supported over 4000 clinical trials through our very well-equipped warehouses in 13 countries across APAC, US and Europe with expertise from more than 200 employees.
We offer:
- Network-wide standardized end-to-end Clinical supply chain solutions to ensure all products and supplies are delivered to specification.
- Specialize in Clinical drug sourcing with a global reach and a strong quality management system. Long-lasting global relationships with manufacturers and wholesalers that help you obtain uninterrupted drugs and ancillary supplies.
- Central and local Secondary packaging solutions that meet GMP standards. Different products have different requirements when it comes to clinical research. Our three distinct supply-chain models: Central depot, Local depot and Hybrid depot ensure we can cater to your specific needs.
Virtue Insight
CONCEPTUALISED BY
Virtue Insight
CONCEPTUALISED BY
Virtue Insight equips business professionals around the world with the latest indepth industry knowledge and provides networking opportunities in the telecom, infrastructure and pharmaceutical industry. Our aim is to provide a platform to share knowledge and insights and provide our event attendees to network effectively and deliver maximum ROI by make new business alliances. We strive to produce high quality conferences which include the latest topics which are delivered by world class leaders of the industry.
Our motto is to offer our customers the expertise and connections for a profitable business. Our events encompass an optimum chance to gain maximum value in terms of networking and an opportunity to sponsor and exhibit to attract new business alliances.
Testimonials
DocRoShGlobal Solutions CEO, Pharma Global Leader
Novo Propharma Manager
Dr. Reddy’s Labs Director – India RA
Venky’s (India) Sr. Quality control Manager
Zuventus Healthcare Clinical Research Associate
Testimonials
Geo-Chem Laboratories General Manager – Operations
Capgemini Technology Sr. Director - Lifesciences Portfolio Leader
Prudentia Management and Technology Consulting Manager, Clinical Coding services
Clinievo Technologies Associate Director – Partnerships
